Skip to Main Content
October 22, 2021
Health Law Weekly

Featured Articles

Fraud and Abuse: A Look at OIG’s Push for Modernized Guidance

HHS Proposes Nixing Trump Administration Rules on Civil Enforcement, Guidance Procedures

Innovation Center Details Strategic Focus for Next Decade

Current Topics

Coronavirus Pandemic Hub

FDA Authorizes Moderna, J&J Boosters; OKs “Mix and Match” Doses

Third Circuit Says COVID-19 Negligence Actions Against Nursing Homes Belong in State Court

Fraud and Compliance

Clinical Lab, Owners Settle False Claims Allegations

Family Practice Clinics Agree to Settlement for Alleged Billing of Medically Unnecessary Services

Medical Testing Lab CEO Agrees to $1.1 Million Settlement of Kickback Allegations

Physician Handed 20 Years in Prison for Improper Opioid Prescribing Resulting in Death

Private Equity Firm, Mental Health Center Executives Agree to $25 Million Settlement of Medicaid Fraud Allegations

U.S. Attorney Announces Additional Enforcement Actions Involving Improper Billing for Electro-Acupuncture Devices

Government Reimbursement

D.C. Circuit Won’t Reconsider Decision Denying Medicare Bad Debt Reimbursement to LTCHs

Eleventh Circuit Scraps Claims Arising From Contractor Audit for Failure to Exhaust Administrative Remedies

OIG: Most Medicare Beneficiaries Had Established Relationships with Providers of Telehealth Services During Pandemic

Senators Introduce Measure to Streamline Prior Authorization Process for Medicare Advantage

Health Care Delivery Models

Groups Urge Flexibility in ACO Benchmarks Citing Pandemic Disruptions

Life Sciences

FDA Approves First Interchangeable Biosimilar Product to Humira

FDA Proposes Allowing Certain Hearing Aids Over the Counter

Fifth Circuit Rejects Product Liability Claims Against Medtronic as Preempted

Patient Care Liability and Litigation

U.S. Court in South Carolina Denies Summary Judgment to Chronic Care Management Provider in Payment Dispute with Medical Center

Current Issue
Health Law Weekly Issue - October 22, 2021